drug

elraglusib

1 story · latest Jul 20, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Actuate Therapeutics Inc.

Timeline

Actuate registers Phase 1/2 trial of oral elraglusib in advanced solid tumors

Jul 20Trial updateActuate Therapeutics Inc.elraglusib

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.